Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Trexan for rheumatoid arthritis and cancer; and Dexdor, Precedex, and Dexmedetomidine products for human use. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other companies. It has discovery service and commercial license agreement with Invenra to develop bispecific antibody cancer therapeutics; and collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.

CEO

Dr. Liisa Hurme Ph.D.

Employees

3943

Country

ISIN

FI0009014377

Listings

0 Comments

Share your thoughts

FAQ

What is Orion stock price today?▼

The current price of ORINF is $78.95 USD — it has increased by +0% in the past 24 hours. Watch Orion stock price performance more closely on the chart.

What is Orion stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Orion stocks are traded under the ticker ORINF.

Is Orion stock price growing?▼

ORINF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Orion has showed a +62.28% increase.

What is Orion market cap?▼

Today Orion has the market capitalization of 4.43B

When is the next Orion earnings date?▼

Orion is going to release the next earnings report on April 30, 2026.

What were Orion earnings last quarter?▼

ORINF earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.07 USD resulting in a -386.61% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Orion revenue for the last year?▼

Orion revenue for the last year amounts to 3.61B USD.

What is Orion net income for the last year?▼

ORINF net income for the last year is -140.2M USD.

Does Orion pay dividends?▼

Yes, ORINF dividends are paid semi-annual. The last dividend per share was 1.04 USD. As of today, Dividend Yield (FWD)% is 2.62%.

How many employees does Orion have?▼

As of April 02, 2026, the company has 3,943 employees.

In which sector is Orion located?▼

Orion operates in the Health Care sector.

When did Orion complete a stock split?▼

Orion has not had any recent stock splits.

Where is Orion headquartered?▼

Orion is headquartered in Espo, FI.